Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.32 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11512701 | 0.93 | ACHE (0.40) | ACHEHPGDALDH1A1LMNATDP1 | |
| SCHEMBL258150 | 0.81 | — | — | |
| SCHEMBL191791 | 0.81 | — | — | |
| SCHEMBL190026 | 0.81 | — | — | |
| SCHEMBL28901712 | 0.81 | ESR2 (0.48) | LMNAKMT2ANPC1RAB9A | |
| SCHEMBL8842286 | 0.77 | ACHE (0.42) | ACHEHPGDALDH1A1LMNATDP1 | |
| SCHEMBL471982 | 0.75 | CA12 (0.46) | HPGDMCL1 | |
| SCHEMBL15303693 | 0.75 | CA1 (0.51) | ALDH1A1TDP1KMT2ATSHR | |
| SCHEMBL914550 | 0.73 | CA12 (0.41) | ACHEHPGDALDH1A1LMNAHTT | |
| SCHEMBL258394 | 0.72 | CA4 (0.38) | ACHEHPGDALDH1A1LMNATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220002317-A1 | AMPK ACTIVATORS | KALLYOPE, INC. | 2022-01-06 | — | — | US | disclosed |
| CN-111566173-A | Coating composition, method for curing the composition, barrier film, and method for producing cured product | 株式会社艾迪科 | 2020-08-21 | — | — | CN | disclosed |
| CN-107636024-B | Composition comprising a metal oxide and a metal oxide | 株式会社艾迪科 | 2020-06-19 | — | — | CN | disclosed |
| EP-2703460-B1 | Inkjet ink composition and method for producing the same, inkjet recording method, pigment dispersion for inkjet ink and method for producing the same | FUJIFILM CORP (JP) | 2018-01-03 | — | — | EP | disclosed |
| US-9080071-B2 | Inkjet ink composition and method for producing the same, inkjet recording method, pigment dispersion for inkjet ink and method for producing the same | FUJIFILM CORPORATION (JP) | 2015-07-14 | — | — | US | disclosed |
| US-20140063127-A1 | INKJET INK COMPOSITION AND METHOD FOR PRODUCING THE SAME, INKJET RECORDING METHOD, PIGMENT DISPERSION FOR INKJET INK AND METHOD FOR PRODUCING THE SAME | FUJIFILM CORPORATION (JP) | 2014-03-06 | — | — | US | disclosed |
| EP-2703460-A1 | Inkjet ink composition and method for producing the same, inkjet recording method, pigment dispersion for inkjet ink and method for producing the same | Fujifilm Corporation (JP) | 2014-03-05 | — | — | EP | disclosed |
| US-20050185232-A1 | Volume hologram recording photosensitive composition and its use | NIPPON PAINT CO., LTD. (JP) | 2005-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220002317-A1 | AMPK ACTIVATORS | PRKAG1, PRKAG2, PRKAA1 | ACHE 924/4885HPGD 1853/4885ALDH1A1 2075/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.